Cargando…
Diversity in modern heart failure trials: Where are we, and where are we going
Over the last three decades, increased attention has been given to the representation of historically underrepresented groups within the landscape of pivotal clinical trials. However, recent events (i.e., coronavirus pandemic) have laid bare the potential continuation of historic inequities in avail...
Autores principales: | Anaba, Uzoma, Ishola, Abiodun, Alabre, Alisha, Bui, Albert, Prince, Marloe, Okafor, Henry, Kola-Kehinde, Onaopepo, Joseph, Joshua J., Mitchell, Darrion, Odei, Bismarck C., Uzendu, Anezi, Williams, Karen Patricia, Capers, Quinn, Addison, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023064/ https://www.ncbi.nlm.nih.gov/pubmed/34920047 http://dx.doi.org/10.1016/j.ijcard.2021.12.018 |
Ejemplares similares
-
Black lives matter … in the cath lab, too! A proposal for the interventional cardiology community to counteract bias and racism
por: Uzendu, Anezi I., et al.
Publicado: (2021) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Managing sarcoma: where have we come from and where are we going?
por: Bleloch, Jenna S., et al.
Publicado: (2017) -
Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008) -
TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)